| Attribute |
Value |
| 52 Week Change |
-0.25517243 |
| Address1 |
1,800 Aston Avenue |
| Address2 |
Suite 100 |
| All Time High |
17.19 |
| All Time Low |
8.5 |
| Ask |
13.93 |
| Ask Size |
2 |
| Audit Risk |
5 |
| Average Analyst Rating |
1.3 - Strong Buy |
| Average Daily Volume10 Day |
201,340 |
| Average Daily Volume3 Month |
171,532 |
| Average Volume |
171,532 |
| Average Volume10Days |
201,340 |
| Bid |
7.87 |
| Bid Size |
2 |
| Board Risk |
9 |
| Book Value |
3.394 |
| City |
Carlsbad |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
7 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
10.986 |
| Current Ratio |
11.879 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
11.1 |
| Day Low |
10.64 |
| Debt To Equity |
18.705 |
| Display Name |
Carlsmed |
| Earnings Call Timestamp End |
1,778,013,000 |
| Earnings Call Timestamp Start |
1,778,013,000 |
| Earnings Timestamp |
1,778,011,200 |
| Earnings Timestamp End |
1,785,960,000 |
| Earnings Timestamp Start |
1,785,960,000 |
| Ebitda |
-33,791,000 |
| Ebitda Margins |
-0.59873 |
| Enterprise To Ebitda |
-6.328 |
| Enterprise To Revenue |
3.789 |
| Enterprise Value |
213,836,272 |
| Eps Current Year |
-1.465 |
| Eps Forward |
-1.435 |
| Eps Trailing Twelve Months |
-0.97 |
| Esg Populated |
0 |
| Exchange |
NMS |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
10.9857 |
| Fifty Day Average Change |
0.0003004074 |
| Fifty Day Average Change Percent |
0.000027345315 |
| Fifty Two Week Change Percent |
-25.517242 |
| Fifty Two Week High |
17.19 |
| Fifty Two Week High Change |
-6.2040005 |
| Fifty Two Week High Change Percent |
-0.36090752 |
| Fifty Two Week Low |
8.5 |
| Fifty Two Week Low Change |
2.486 |
| Fifty Two Week Low Change Percent |
0.2924706 |
| Fifty Two Week Range |
8.5 - 17.19 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,753,277,400,000 |
| Float Shares |
15,551,141 |
| Forward Eps |
-1.435 |
| Forward P E |
-7.6557493 |
| Free Cashflow |
-26,400,876 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
127 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.75887 |
| Gross Profits |
42,829,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.43732 |
| Held Percent Institutions |
0.40523 |
| Implied Shares Outstanding |
27,184,933 |
| Industry |
Health Information Services |
| Industry Disp |
Health Information Services |
| Industry Key |
health-information-services |
| Ipo Expected Date |
2,025-07-23 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California. |
| Long Name |
Carlsmed, Inc. |
| Market |
us_market |
| Market Cap |
298,653,664 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_629940925 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
-32,601,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
294,140,975 |
| Number Of Analyst Opinions |
6 |
| Open |
10.64 |
| Operating Cashflow |
-33,829,000 |
| Operating Margins |
-0.57558 |
| Overall Risk |
8 |
| Payout Ratio |
0.0 |
| Phone |
760 766 1923 |
| Previous Close |
10.8 |
| Price Eps Current Year |
-7.4989758 |
| Price Hint |
2 |
| Price To Book |
3.2368886 |
| Price To Sales Trailing12 Months |
5.2917123 |
| Profit Margins |
-0.57764 |
| Quick Ratio |
11.249 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.33333 |
| Region |
US |
| Regular Market Change |
0.18599987 |
| Regular Market Change Percent |
1.722221 |
| Regular Market Day High |
11.1 |
| Regular Market Day Low |
10.64 |
| Regular Market Day Range |
10.64 - 11.1 |
| Regular Market Open |
10.64 |
| Regular Market Previous Close |
10.8 |
| Regular Market Price |
10.986 |
| Regular Market Time |
1,784,124,987 |
| Regular Market Volume |
17,208 |
| Return On Assets |
-0.24158001 |
| Return On Equity |
-0.52427 |
| Revenue Growth |
0.582 |
| Revenue Per Share |
2.842 |
| Sand P52 Week Change |
0.2043345 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
8 |
| Shares Outstanding |
27,184,933 |
| Shares Percent Shares Out |
0.048299998 |
| Shares Short |
1,313,385 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
1,307,106 |
| Short Name |
Carlsmed, Inc. |
| Short Percent Of Float |
0.1299 |
| Short Ratio |
10.54 |
| Source Interval |
15 |
| State |
CA |
| Symbol |
CARL |
| Target High Price |
23.0 |
| Target Low Price |
16.0 |
| Target Mean Price |
18.16667 |
| Target Median Price |
17.5 |
| Total Cash |
97,016,000 |
| Total Cash Per Share |
3.569 |
| Total Debt |
17,255,000 |
| Total Revenue |
56,438,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.97 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
12.008075 |
| Two Hundred Day Average Change |
-1.0220747 |
| Two Hundred Day Average Change Percent |
-0.08511562 |
| Type Disp |
Equity |
| Volume |
17,208 |
| Website |
https://carlsmed.com |
| Zip |
92,008 |